abrdn Life Sciences Investors (HQL) vs Brookfield Real Assets Income Fund (RA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
On valuation, abrdn Life Sciences Investors trades at a lower trailing P/E (2.6x vs 12.0x for Brookfield Real Assets Income Fund). abrdn Life Sciences Investors pays a dividend yielding 10.88%, while Brookfield Real Assets Income Fund does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | HQL | RA |
|---|---|---|
| Share price | $17.56 | $11.51 |
| Market cap | — | $635.98M |
| 1-day change | 0.00% | -0.78% |
| YTD return | +4.65% | — |
| 1-year return | +11.21% | — |
| 5-year return | -15.00% | — |
| P/E ratio (TTM) | 2.64 | 11.99 |
| EPS (TTM) | $6.64 | $0.96 |
| Dividend yield | 10.88% | 12.21% |
| Annual dividend | $1.91 | $0.00 |
| 52-week high | $22.67 | $13.59 |
| 52-week low | $15.66 | $11.41 |
| Distance from 52-week high | -22.54% | -15.31% |
| Average volume | 148.17K | 200.09K |
| Shares outstanding | — | 55.25M |
| Sector | Finance | Finance |
| Industry | Investment Managers | Investment Managers |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Brookfield Real Assets Income Fund trades at a higher earnings multiple (12.0x vs 2.6x trailing P/E).
- Brookfield Real Assets Income Fund offers a meaningfully higher dividend yield (12.21% vs 10.88%).
HQL vs RA FAQ
Which has the lower P/E ratio, HQL or RA?
HQL has the lower trailing P/E at 2.6, versus 12.0 for RA. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, abrdn Life Sciences Investors or Brookfield Real Assets Income Fund?
Brookfield Real Assets Income Fund has the higher yield at 12.21%, compared with 10.88% for abrdn Life Sciences Investors.
Are abrdn Life Sciences Investors and Brookfield Real Assets Income Fund in the same industry?
Yes. Both are classified in the Investment Managers industry within the Finance sector.